In the published article, there was an error in Figure 7 as published. The x-axis labels in Figure 7B and Figure 7D were listed as ‘contr.’ and ‘T’, respectively. However, the correct x-axis labels should be ‘contr.’ and ‘CP’, as these two graphs display data from CP-724714-treated cells (CP) and not from Tucatinib-treated cells (T). The corrected Figure 7 and its caption appear below.
Figure 7
In the published article, there was an error. The CD151-specific antibody used for the WB was not described correctly. A correction has been made to Section 2 Materials and methods, Sub-section Antibodies, inhibitors, and plasmids, Paragraph 1. This sentence previously stated: ‘A rabbit pAb raised against CD151 (ab185684) used for STED experiments was purchased from (Abcam, Amsterdam, Netherlands) and CD151-specific mouse mAb antibody (11G5a) for WB from Bio-Rad (Munich, Germany).’ The corrected sentence appears below:
‘A rabbit pAb raised against CD151 (ab185684) used for STED experiments was purchased from Abcam (Amsterdam, Netherlands) and a rabbit anti-CD151 serum generated against the recombinant large extracellular loop of CD151 (rCD151) used for WB after non-reducing SDS-PAGE was a kind gift from Fedor Berditchevski (University of Birmingham, United Kingdom).’
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
human papillomavirus, HPV16, promoter activity, ErbB2, HER2/neu, tyrosine kinase inhibitor, tucatinib, E6 E7 oncogene expression
Citation
Mikuličić S, Shamun M, Massenberg A, Franke A-L, Freitag K, Döring T, Strunk J, Tenzer S, Lang T and Florin L (2024) Corrigendum: ErbB2/HER2 receptor tyrosine kinase regulates human papillomavirus promoter activity. Front. Immunol. 15:1385729. doi: 10.3389/fimmu.2024.1385729
Received
13 February 2024
Accepted
19 February 2024
Published
29 February 2024
Volume
15 - 2024
Edited and reviewed by
Mirko Trilling, University of Duisburg-Essen, Germany
Updates
Copyright
© 2024 Mikuličić, Shamun, Massenberg, Franke, Freitag, Döring, Strunk, Tenzer, Lang and Florin.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Luise Florin, lflorin@uni-mainz.de
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.